“Codivir Showed Great Success in Clinical Trials”

Zyon Ayni - TradeArabia

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Zyon Ayni, Founder and CEO of Code Pharma, was quoted on TradeArabia: “Codivir showed great success in clinical trials and already has received emergency approvals in different countries for the treatment of coronavirus patients”.

Ayni added: “Our team at Code Pharma are now initiating a multi-country phase 2 study with a larger cohort and has submitted additional emergency approval requests to several affected countries. Our phase 1 study with Codivir in Brazil has proven the medication to be safe, and we were able also to demonstrate a reduction in the viral load of the patients during the course of the treatment”.